ArticleJournal of diabetes research2026
Metformin and Placental Ferroptosis in Gestational Diabetes: A Mechanistic Study.
Article in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metformin and Placental Ferroptosis in Gestational Diabetes: A Mechanistic Study.Journal of diabetes research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gestational diabetes mellitus (GDM) is a major contributor to adverse pregnancy outcomes. Although the involvement of ferroptosis in GDM pathogenesis has been recognized, the precise mechanisms remain incompletely understood. This study is aimed at investigating the potential regulatory effects of metformin (Met) on ferroptosis in GDM. Patients with GDM were stratified into four groups: diet-controlled (Group 1), nonmedicated (Group 2), Met-treated (Group Met), insulin-treated (Group Ins), alongside healthy controls (Group N). Placental trophoblasts and HTR-8/SVneo cells were subjected to analysis using transmission electron microscopy (ultrastructure), Prussian blue staining (iron detection), CCK-8 assay (proliferation), DCFH-DA probe (reactive oxygen species [ROS]), and biochemical assays (Fe
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.